PBH - Company ID 0001295947
The table below shows Prestige Consumer Healthcare Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $283.44M | $274.11M | $249.53M | $290.32M | $283.79M | $267.14M |
| Cost of revenue | $126.08M | $122.53M | $109.20M | $129.27M | $126.40M | $121.12M |
| Gross profit | $157.37M | $151.58M | $140.33M | $161.05M | $157.38M | $146.02M |
| R&D | - | - | - | - | - | - |
Prestige Consumer Healthcare Inc. reported annual revenue of $1.09B for fiscal year 2026. That is down 4.3% from $1.14B in fiscal 2025. Over the 10 fiscal years shown, annual revenue grew from $882.06M (FY 2017) to $1.09B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $29.67M | $28.04M | $28.46M | $26.18M | $26.07M | $28.91M |
| Operating income | $82.49M | $79.67M | $71.76M | $91.96M | $84.34M | $72.05M |
| Income tax | $15.12M | $26.92M | $14.31M | $19.12M | $17.29M | $9.35M |
| Net income | $46.70M | $42.21M | $47.47M | $61.03M | $54.38M | $49.07M |
| EPS (diluted) | $0.97 | $0.86 | $0.95 | $1.22 | $1.09 | $0.98 |